Cassava Sciences (SAVA) stock is surging over the last two trading sessions. Appears the larger marketplace is seeing that the citizens petition filed with the FDA was a fraud as were the players who filed the petition (all holding short positions in the stock). So far, terrific results in its Phase 2 and Phase 3 trials that were in large part designed in collaboration with the FDA. Alzheimers is a tragic disease and hoping SAVA's treatment is a huge advancement in controlling AD.
Leave a Reply